MEDS Stock Overview
About the company
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.
Snowflake Analysis
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
TRxADE HEALTH, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.37 |
| 52 Week High | US$3.47 |
| 52 Week Low | US$0.27 |
| Beta | 1.06 |
| 1 Month Change | 5.63% |
| 3 Month Change | -21.32% |
| 1 Year Change | -83.42% |
| 3 Year Change | -94.58% |
| 5 Year Change | -85.67% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
TRxADE Health prices of $1.8M stock offering
Oct 05TRxADE Health launches next day delivery services via Trxade prime plus program
Aug 30TRxADE Health proposes public stock offering
Aug 23Trxade Group GAAP EPS of -$0.13 misses by $0.05, revenue of $3.3M beats by $0.37M
Jul 25Will TRxADE HEALTH (NASDAQ:MEDS) Spend Its Cash Wisely?
Mar 30
Here's Why We're Watching TRxADE HEALTH's (NASDAQ:MEDS) Cash Burn Situation
Nov 23Need To Know: Analysts Just Made A Substantial Cut To Their TRxADE HEALTH, Inc. (NASDAQ:MEDS) Estimates
Jul 29Pharma Pain Points - Trxade CEO Suren Ajjarapu (Video)
Jun 16SpartanNash and Bonum Health join hands to provide telemedicine services
Jun 07Shareholders Will Probably Hold Off On Increasing Trxade Group, Inc.'s (NASDAQ:MEDS) CEO Compensation For The Time Being
May 22Earnings Release: Here's Why Analysts Cut Their Trxade Group, Inc. (NASDAQ:MEDS) Price Target To US$10.00
Apr 28Time To Worry? Analysts Just Downgraded Their Trxade Group, Inc. (NASDAQ:MEDS) Outlook
Apr 01Did Business Growth Power Trxade Group's (NASDAQ:MEDS) Share Price Gain of 143%?
Feb 05Shareholder Returns
| MEDS | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 4.2% | 2.4% | 2.1% |
| 1Y | -83.4% | -26.4% | -12.8% |
Return vs Industry: MEDS underperformed the US Healthcare Services industry which returned -28% over the past year.
Return vs Market: MEDS underperformed the US Market which returned -13.7% over the past year.
Price Volatility
| MEDS volatility | |
|---|---|
| MEDS Average Weekly Movement | 23.6% |
| Healthcare Services Industry Average Movement | 9.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: MEDS is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 24% a week.
Volatility Over Time: MEDS's weekly volatility has increased from 17% to 24% over the past year.
TRxADE HEALTH, Inc. Fundamentals Summary
| MEDS fundamental statistics | |
|---|---|
| Market Cap | US$3.45m |
| Earnings (TTM) | -US$3.33m |
| Revenue (TTM) | US$11.31m |
0.3x
P/S Ratio-1.0x
P/E RatioIs MEDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDS income statement (TTM) | |
|---|---|
| Revenue | US$11.31m |
| Cost of Revenue | US$6.16m |
| Gross Profit | US$5.15m |
| Other Expenses | US$8.48m |
| Earnings | -US$3.33m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Mar 27, 2023
| Earnings per share (EPS) | -0.36 |
| Gross Margin | 45.54% |
| Net Profit Margin | -29.46% |
| Debt/Equity Ratio | 36.9% |
How did MEDS perform over the long term?
See historical performance and comparison